Cargando…

Barriers to participation in HIV vaccine trials and cancer trials: a cost-gain analysis

Detalles Bibliográficos
Autores principales:	Dhalla, S, Poole, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441758/ http://dx.doi.org/10.1186/1742-4690-9-S2-P109

Ejemplares similares

Motivators to participation in HIV vaccine trials and cancer trials: the application of personal and social categorization
por: Dhalla, S, et al.
Publicado: (2012)

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
por: Penezina, O, et al.
Publicado: (2012)

Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda
por: Nanvubya, A, et al.
Publicado: (2012)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
por: Poole, D, et al.
Publicado: (2012)

Willingness to participate in vaccine trials among MSM in São Paulo, Brazil
por: Calazans, G, et al.
Publicado: (2012)

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
por: Morgan, C, et al.
Publicado: (2012)

P04.86. Socio-demographic variations in barriers to participation in an acupuncture clinical trial
por: Tan, T, et al.
Publicado: (2012)

P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
por: Schmidt, C, et al.
Publicado: (2009)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

P15-25. Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso
por: Berthe, A, et al.
Publicado: (2009)

P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation
por: Sitar, S, et al.
Publicado: (2009)

Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials
por: Mbogua, J, et al.
Publicado: (2012)

P19-27. Willingness of adolescents in Soweto, South Africa to participate in future HIV prevention trials
por: Makongoza, N, et al.
Publicado: (2009)

A social ecological model of willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India
por: Chakrapani, V, et al.
Publicado: (2012)

Using an internet consumer marketing strategy to reach men who have sex with men for participation in a preventive HIV vaccine clinical trial
por: Voytek, CD, et al.
Publicado: (2012)

Estimation of cost-effectiveness in randomised controlled trials when not all participants allocated to active intervention receive it
por: Metcalfe, Chris
Publicado: (2011)

Surveying clinical trial participant satisfaction
por: Bray, Christopher
Publicado: (2015)

P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem
por: Routy, J, et al.
Publicado: (2009)

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
por: de Bruyn, G, et al.
Publicado: (2009)

P05.35. What are participants in clinical trials told about placebos? A content analysis of participant information leaflets
por: Bishop, F, et al.
Publicado: (2012)

P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009
por: Tounkara, K, et al.
Publicado: (2009)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia
por: Bourinbaiar, Aldar, et al.
Publicado: (2010)

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
por: Latka, M, et al.
Publicado: (2009)

P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria
por: Adeyemi, AO, et al.
Publicado: (2009)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama
por: Alexander, SB, et al.
Publicado: (2009)

Female sex workers and condom use: lessons for future HIV vaccine trial in Nigeria
por: Fakunle, O, et al.
Publicado: (2012)

Protection of human research participants through routine inspection of ongoing HIV prevention and treatment clinical trials: experiences from Zimbabwe
por: Zinyama-Gutsire, RB, et al.
Publicado: (2012)

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
por: Volk, JE, et al.
Publicado: (2012)

Do participants in major, practice-changing breast cancer trials reflect the breast cancer patient population?
por: Treweek, Shaun, et al.
Publicado: (2013)

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
por: Mpendo, J, et al.
Publicado: (2009)

HIV risk among men who have sex with men (MSM) in Nigeria: a potential population for HIV vaccine trial
por: Adeyemi, AO, et al.
Publicado: (2012)

Experience in recruiting youths in HIV vaccine trials in Tanzania: the TaMoVac 01 study
por: Massawa, T, et al.
Publicado: (2012)

Cost-efficacy analysis of the MONET trial using Spanish antiretroviral drug prices
por: Arribas, JR, et al.
Publicado: (2010)

P06-09. Web based interviewing system for HIV-behavior research in the settings of vaccine and non vaccine prevention trials
por: Peinado, JE, et al.
Publicado: (2009)

The trialists’ perspectives on the participant retention in mental health randomised controlled trials
por: Szymczynska, Paulina, et al.
Publicado: (2015)

Systematic review and meta-analysis of the participation rates in clinical trials evaluating non-pharmacological interventions for psychosis
por: Szymczynska, Paulina, et al.
Publicado: (2015)

P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India
por: Kochhar, S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a6cs5qasg3f74v4tbmgdil7ffp